Back to Search
ANITA HANCOCK, MD
MD
Pediatrics Physician
NPI: 1487634408Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Does 5-bromo-2'-deoxyuridine (BrdU) disrupt cell proliferation and neuronal maturation in the adult rat hippocampus in vivo?
PMID 19121338·Behav Brain Res·2009
7-preclinical
The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
PMID 16513092·Biochem Pharmacol·2006
6-review
Distinctions and contradistinctions between antiobesity histamine H(3) receptor (H (3)R) antagonists compared to cognition-enhancing H (3) receptor antagonists.
PMID 16547814·Inflamm Res·2006
7-preclinical
Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists.
PMID 15833055·Expert Opin Investig Drugs·2005
6-review
Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy.
PMID 15928821·Inflamm Res·2005
7-preclinical
In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists.
PMID 15447739·Basic Clin Pharmacol Toxicol·2004
7-preclinical
Perspectives on cognitive domains, H3 receptor ligands and neurological disease.
PMID 15461554·Expert Opin Investig Drugs·2004
6-review
Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist.
PMID 15033391·Eur J Pharmacol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 610 NW 11TH ST STE E33
HERMISTON, OR 97838 - Phone
- (541) 667-3740
Quick Facts
- NPI
- 1487634408
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile